References
- Cartwright J, Duncan WC, Horne AW. 2009. Serum biomarkers of tubal ectopic pregnancy: current candidates and future possibilities. Reproduction 138:9–22.
- Chang J, Elam-Evans LD, Berg CJ, Herndon J, Flowers L, Seed KA, et al. 2003. Pregnancy-related mortality surveillance- United States. 1991–1999. MMWR Surveill Summ 52:1–8.
- Chetty M, Sawyer E, Dew T, Chapman AJ, Elson J, 2011. The use of novel biochemical markers in predicting spontaneously resolving ‘pregnancies of unknown location’. Human Reproduction 26:1318–23. Epub 2011 Mar 18.
- Daponte A, Pournaras S, Zintzaras E, Kallitsaris A, Lialios G, Maniatis AN, 2005. The value of a single combined measurement of VEGF, glycodelin, progesterone, PAPP-A, HPL and LIF for differentiating between ectopic and abnormal intrauterine pregnancy. Human Reproduction 20: 3163–3166.
- Hitoglou S, Hatzistilianou M, Gougoustamou D, Athanassiadou F, Kotsis A, Catriu D. 2001. Adenosine deaminase activity and its isoenzyme pattern in patients with juvenile rheumatoid arthritis and systemic lupus erythematosus. Clinical Rheumatology 20:411–416.
- Jaqueti J, Martinez-Hernandez D, Hernandez-Garcia R, Navarro-Gallar F, Arenas-Barbero J. 1990. Adenosine deaminase in pregnancy serum. Clinical Chemistry 36:2144.
- Kucera-Sliutz E, Schiebel I, Konig F, Leodolter S, Sliutz G, Koelbl H. 2002. Vascular endothelial growth factor (VEGF) and discrimination between abnormal intrauterine and ectopic pregnancy. Human Reproduction 17:3231–3234.
- Lee SJ, Hwang HS, Kim BN, Kim MA, Lee JW, Park YW, Kim YH. 2007. Changes in serum adenosine deaminase activity during normal pregnancy. Journal of Korean Medical Science 22:718–721.
- Melzig M, Paun J. 1992. Modulation of adenosine deaminase activity of endothelial cells by steroids. Pharmazie 47:H5.
- Mosmann TR, Sad S. 1996. The expanding universe of T-cell subsets: Th1, Th and more. Immunol Today;17:138–46 Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th and more. Immunology Today 1996;17:138–146.
- Mueller MD, Raio L, Spoerri S, Ghezzi F, Dreher E, Bersinger NA. 2004. Novel placental and nonplacental serum markers in ectopic versus normal intrauterine pregnancy. Fertility and Sterility 81:1106–1111.
- Oladipo O, Afolabi B, Okorodudu A. 2009. Adenosine deaminase activity in subjects with normal pregnancy, pregnancy induced hypertension and pre-eclampsia. West African Journal of Medicine 28:161–164.
- Rausch ME, Barnhart KT. 2012. Serum biomarkers for detecting ectopic pregnancy. Clinical Obstetrics and Gynecology 55:418–423.
- Soriano D, Hugol D, Quang NT, Darai E. 2003. Serum concentrations of interleukin-2R (IL-2R), IL-6, IL-8, and tumor necrosis factor alpha in patients with ectopic pregnancy. Fertility and Sterility 79:975–980.
- Ungerer JP, Oosthuizen HM, Bissbort SH, Vermmak WJ. 1992. Serum adenosine deaminase: isoenzymes and diagnostic application. Clinical Chemistry 38:1322–1326.
- Wegmann TG, Lin H, Guilbert L, Mosmann TR. 1993. Bidirectional cytokine interactions in the maternal-fetal relationship:Is successful pregnancy a TH2 phenomenon? Immunology Today 14:353–356.
- Yoneyama Y, Sawa R, Suzuki S, Otsubo Y, Araki T. 2002a. Serum adenosine deaminase activity in women with hyperemesis gravidarum. Clinica Chimica Acta 324:141–145.
- Yoneyama Y, Sawa R, Suzuki S, Yoneyama K, Doi D, Araki T. 2002b. Relationship Between Adenosine Deaminase Activity and Cytokine-Secreting T Cells in Normal Pregnancy. Obstetrics & Gynecology 100:754.
- Yoneyama Y, Suzuki S, Sawa R, Otsubo Y, Miura A, Kuwabara Y, et al. 2003. Serum adenosine deaminase activity and its isoenzyme pattern in women with normal pregnancies. Archives of Gynecology and Obstetrics 267:205–207.